Aptose Biosciences Correlations
APTO Stock | USD 3.60 3.49 3,173% |
A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aptose Biosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aptose Biosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
Aptose Biosciences Correlation With Market
Very good diversification
The correlation between Aptose Biosciences and DJI is -0.3 (i.e., Very good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Aptose Biosciences and DJI in the same portfolio, assuming nothing else is changed.
Aptose |
Moving against Aptose Stock
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Aptose Stock performing well and Aptose Biosciences Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Aptose Biosciences' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
CTMX | 3.88 | (0.24) | 0.00 | (0.11) | 0.00 | 7.32 | 23.37 | |||
TIL | 5.91 | (0.15) | 0.00 | (0.45) | 0.00 | 14.84 | 33.50 | |||
NLTX | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
SPRO | 2.58 | (0.48) | 0.00 | (0.73) | 0.00 | 4.85 | 21.98 | |||
ASMB | 2.97 | (0.31) | 0.00 | (0.21) | 0.00 | 6.63 | 24.82 | |||
FBIO | 3.39 | 0.22 | 0.07 | 3.15 | 3.03 | 9.76 | 24.02 | |||
MBIO | 5.53 | (1.74) | 0.00 | 0.40 | 0.00 | 15.38 | 53.88 | |||
ACHL | 1.61 | 0.46 | 0.26 | 0.79 | 0.93 | 2.59 | 22.15 | |||
FBIOP | 2.76 | 0.33 | 0.11 | (0.47) | 2.82 | 7.44 | 21.73 | |||
GANX | 4.72 | 0.37 | 0.07 | (0.41) | 5.02 | 10.41 | 32.23 |
Aptose Biosciences Corporate Management
Brooks MBA | VP Controller | Profile | |
Philippe Ledru | Senior Officer | Profile | |
Janet CA | VP Fin | Profile | |
Rafael MD | Senior Officer | Profile | |
Roger BSc | Vice Operations | Profile | |
Marc Wiles | Senior Affairs | Profile |